Noteworthy - Pharmaceutical Executive



Dealmaking: Staying Ahead of the Curve

October 1, 2014

Amid the continued surge in M&A activity, Michael Swanick asks, what are the crucial considerations pharma executives should weigh before sitting down at the deals table?

Crowdfunding: The Open-Source Option Against Capital Crunch

October 1, 2014

Is crowdfunding an attractive alternative to finance pharma and biotech start-ups? Seth R. Ogden and M. Andrew Holtman report.

TAG Touts Progress in Global Access to TB Drugs

October 14, 2014

TB advocacy campaigner Treatment Action Group (TAG) has reached a milestone in improving access to TB treatments. Casey McDonald reports.

Unlocking the True Value of Big Data

October 9, 2014

In this special issue of Pharm Exec Global Digest: Unlocking the true value of Big Data; Data privacy and the health sciences; In-silico modeling and real-word outcomes; and more...

IDEAlogue for Innovation: A Conversation with Italy's Fabio Pammolli

October 6, 2014

Fabio Pammolli, selected by the European Commission to author a set of critical overviews on the pharma sector, talks about the need for a dramatic change in industrial strategy.

How the "Millennials" Demographic is Shaping US Healthcare

October 6, 2014

The US is skewing young again, and the "millennials" have the clout to color everything from the nation's cultural landscape to the conduct of business practices like marketing and customer engagement, writes Bill Looney.

Italy's AIFA: Agenda for Regulatory Leadership

October 2, 2014

Pharm Exec talks with Dr. Sergio Pecorelli, Chairman of the Italian Medicines Agency (AIFA), an organization respected in global regulatory circles for its precedent-setting work on advanced cost-effectiveness metrics.

"Sunshine" Goes Live — Despite Incomplete Information

October 1, 2014

The federal Open Payments program has gone live, but biopharma companies continue to be concerned about the lack of context. Jill Wechsler reports.

Investing in African Healthcare: Study, Share, Act — and Grow

September 18, 2014

Is sub-Saharan Africa a jewel box of untapped assets for a growth-obsessed big Pharma? Pharm Exec speaks with Steven Adjei, partner of an investment firm focused on opportunities in the region.


Click here